SCHEMBL30968188

SCHEMBL30968188

CC(C)(C)OC(=O)N1CCNCC1(N)CC=NO

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 1/20 0.30
CRBN Q96SW2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5315606 0.82 CTSK (0.33) DDB1CRBN
SCHEMBL4394294 0.72 CTSK (0.31)
SCHEMBL29713535 0.72 DDB1 (0.32) DDB1CRBN
SCHEMBL28724815 0.71 USP2 (0.38) DDB1CRBN
SCHEMBL324691 0.71 USP2 (0.38) DDB1CRBN
SCHEMBL13733035 0.71 CTSK (0.33) DDB1CRBN
SCHEMBL24596421 0.71
SCHEMBL38663950 0.70 USP2 (0.37) DDB1CRBN
Hydrochloric Acid SCHEMBL18096129 0.70 USP2 (0.37) DDB1CRBN
SCHEMBL1044272 0.70 USP2 (0.37) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113227071-B Amide-substituted heterocyclic compounds for the treatment of disorders associated with modulation of IL-12, IL-23 and/or IFN-alpha 百时美施贵宝公司 2024-06-25 CN disclosed